WE CAN HELP
Book a FREE consultation  
For a free consultation or assistance, please call 020 7730 6666

Hair Loss Blog

Browse by Category

Cicatricial Alopecia refers to a group of conditions which all the hair follicles are permanently destroyed, leading to scarring hair loss which is often permanent.

It is generally diagnosed via a scalp biopsy, though some forms of cicatricial alopecia, such as Frontal Fibrosing Alopecia, present in established patterns and so may be spotted by a hair loss specialist via a simple visual assessment.

A report published in the Skin Research & Technology journal on 29th May 2019 by members of the dermatology and radiology departments from the Faculty of Medicine at Selcuk University, Selçuklu, Turkey, explains their use of ultrasound techniques as a novel approach to exploring Cicatricial Alopecia.

ultrasound machine

Examining tissues using ultrasound

The reason scalp biopsies tend to be used in diagnosing Cicatricial Alopecias is that it is an effective method of showing the level of inflammation present.

As such, for conditions where there are few outward signs other than this inflammation, the biopsy method is currently extremely useful.

This Turkish study employed a combination of shear wave elastography (SWE) and superb microvascular imaging (SMI) to explore the differences between areas of cicatricial alopecia and unaffected ‘normal’ scalp areas. Researchers aimed to establish how feasible it would be to use these technologies for such assessments.

Using an Aplio 500 system for the trials, these “noninvasive ultrasonic techniques” evaluated thickness, stiffness, and the vascular index of skin tissues in 17 patients with Cicatricial Alopecia as well as 20 healthy control participants without hair loss.

The mean age of patients in the Cicatricial Alopecia group was 37 years old (± 13.16), whilst for the healthy controls it was 36 years of age (± 11.79).

SWE results in cicatricial plaques were found to be higher than healthy, unaffected scalp areas in patient group; SMI values for the Cicatricial Alopecia patient group were noted as being “significantly higher” than those recorded for the control group.

The full results can be found in the report abstract.

Study conclusions

In conclusion, the study authors state, “To the best of our knowledge, this is the first study to evaluate SWE and SMI scores in cicatricial alopecia. We found higher stiffness and vascularity in patient group. We conclude that SWE and SMI can show fibrosis and inflammation like previous studies. Especially, SWE as m/s is more sensitive than as kPa for cicatricial alopecia”.

Therefore it seems these ultrasound techniques may be beneficial in helping to determine factors associated with Cicatricial Alopecia.

Whether or not they could potentially replace the need for diagnosis using a scalp biopsy where scarring hair loss is suspected, remains to be seen, though.

Presently there are a limited number of scarring hairloss conditions which can be treated, such as Follicular Degeneration Sydrome. It is often the case that treatment revolves around the patient’s doctor or dermatologist prescribing them medication to help manage the associated inflammation, rather than using anything for hair regrowth.

Sometimes hair restoration surgery may be a viable option but, as there are many factors involved in determining whether a patient is suitable for a hair transplant – including scalp health, blood supply to scarred areas and the availability of enough good quality donor hair – this is decided on a case-by-case basis by highly-specialist surgeons.


Circ - Belgravia Centre Hair Loss Clinics LondonThe Belgravia Centre

The Belgravia Centre is an organisation specialising in hair growth and hair loss prevention with two clinics and in-house pharmacies in Central London, UK. If you are worried about hair loss you can arrange a free consultation with a hair loss expert or complete our Online Consultation Form from anywhere in the world. View our Hair Loss Success Stories, which includes the world’s largest gallery of hair growth comparison photos and demonstrates the levels of success that so many of Belgravia’s patients achieve. You can also phone 020 7730 6666 any time to arrange a free consultation.

Related Stories


Belgravia Centre Hair Loss Treatment Before and After Results - New Success Story

A new entry has just been added to Belgravia’s Female Pattern Hair Loss Treatment Success Stories gallery.

Find out what this client had to say and see her regrowth results close up, or find out more about treating hereditary hair loss in women by clicking the buttons below…

(Results may vary and are not guaranteed)

VIEW SUCCESS STORY

Treatment information


Circ - Belgravia Centre Hair Loss Clinics LondonThe Belgravia Centre

The Belgravia Centre is an organisation specialising in hair growth and hair loss prevention with two clinics and in-house pharmacies in Central London, UK. If you are worried about hair loss you can arrange a free consultation with a hair loss expert or complete our Online Consultation Form from anywhere in the world. View our Hair Loss Success Stories, which includes the world’s largest gallery of hair growth comparison photos and demonstrates the levels of success that so many of Belgravia’s patients achieve. You can also phone 020 7730 6666 any time to arrange a free consultation.

A short paper published in the Dermatologic Therapy journal on 6th June 2019 outlines the outcome from using Biofibre® artificial hair implants on men and women with hair loss.

This method, which has been in development for over ten years, implants synthetic hairs during a hair transplant operation, and, the company stresses, must be carried out by a specifically trained professional, not least because it involves using new, proprietary MediCap equipment.

The key conditions this was used to address were Male Pattern Baldness, Female Pattern Hair Loss and scarring alopecia, also known as Cicatricial Alopecia.

Hair transplant surgery

During normal hair transplant operations, donor hair is required. This is the term for follicles harvested from areas of the patient’s scalp which are unaffected by their specific hair loss condition. These follicles are then implanted into incisions in the sparser areas they want to fill out.

For example, in the case of Female or Male Pattern Baldness, which affects the follicles along the top of the head, from hairline and temples to crown, only, ‘donor hair’ is taken from the sides and/or back of the head.

Where there is not enough good quality donor hair available, hair restoration surgery may not be possible; this tends to be the case where the patient has extensive follicular damage, either through advanced baldness, where the scalp has taken on a smooth, shiny appearance, or due to scarring.

This is one of the reasons why hair transplants for Cicatricial Alopecia patients, who have often lost their hair to scarring caused by burns or injury, are decided on a case-by-case basis by specialist surgeons, rather than there being a general rule about it being a suitable procedure for those with this condition.

Biofibre® hair implantation system

Biofibre® hair implantation system negates the need for donor hair as it uses artificial hair, which the peer-reviewed, published report describes as having “special physical, chemical and mechanical features”.

According to Biofibre marketing literature, the out-patient procedure requires no down-time and can be done at a rate of 800 hairs implanted per hour, in order to provide a ‘high hair density’ result. The average number per procedure is 2,500 synthetic strands. Continues below…

They offer 14 different hair colours, and strands of different lengths that mimic all hair types and textures, plus further claim that it is a painless and reversible op. Also, as the hair is not real, it will not age or go grey.

There are, however, a number of downsides to this promising-sounding surgery. Additional ‘touch-up’ surgeries may be needed in order to maintain the initial look, and patients will need to follow scalp- and hair-aftercare both to properly preserve their results and for hygiene reasons.

The artificial hairs are believed to last around 7 to 8 years, and shed at a rate of approximately 10 per cent per year.

The Biofibre® hair implantation system is not suitable for everyone; the company website states that patients who are sensitive to “the pre-implant test or suffering from scalp diseases or overall illness, such as diabetes, lupus, HIV, hepatitis, autoimmune diseases, etc.” will find the system “cannot be be used in all scalp area with same degree of performance”.

Potential hair loss solution for some candidates

If a hair transplant candidate no longer needs to have sufficient – or, indeed, any – donor hair, it widens the scope of those who may be suitable for this type of surgery.

Biofibre Hair Implants System hair transplant synthetic hair

There are already clinically-proven, MHRA-licensed and FDA-approved hair loss treatments available for Male and Female Pattern Baldness, which can be used so long as the follicles are still functioning – even if they only produce thinning hair – and the individuals are deemed medically-suitable.

In cases of true baldness – which is rarely seen in women with genetic hairloss, but common in men – and Cicatricial Alopecia, there are currently no widely accepted remedies, other than cosmetic solutions, such as wigs.

Therefore, should this innovation prove viable, this may provide men and women who may currently have no real options for getting their hair back, with a way to have a full head of hair again. This is, of course, as long as the procedure and materials are proven to be both safe and effective for long-term use.

Furthermore, whereas with a regular FUE or FUT hair restoration operation it can take around 12 months to see the full results of the procedure, the results from Biofibre® hair implantation, using a novel CE 0373 certified medical device, are said to be instant – something that will no doubt appeal to clients who want on-demand, ‘quick-fix’ hair loss solutions.

An international team* studied how the synthetic hair implants performed on 1,518 patients – a mix of men and women – with varying degrees of baldness from genetic hair loss or burns and scars.

Their findings state: “According to our experience, this technique gives immediate and visible results without scarring or hospitalization and the aesthetic results are very encouraging for both male and female patients with a rapid recovery of self‐esteem and psychological well‐being.”

We look forward to seeing wider-ranging trials involving this innovative system, which does not yet have FDA-clearance but has been authorised by its Australian equivalent body, and will report on any updates here on the Belgravia blog.

*The researchers came from the Department of Dermatology at the University of Parma, the Clinic of Dermatology in Ferrara, and the Department of Dermatology at Rome’s University G. Marconi, all in Italy, the Department of Dermatology at University Cluj‐Napoca in Romania, the Department of Dermatology at Fortis Hospital, Shalimar Bagh, India, the University of Cairo’s Department of Dermatology in Egypt, and both the Department of General, Vascular and Abdominal Surgery, and the Department of Dermatology, Venereology and Dermatologic surgery, at the Medical Institute of Ministry of Interior in Sofia, Bulgaria.

Circ - Belgravia Centre Hair Loss Clinics LondonThe Belgravia Centre

The Belgravia Centre is an organisation specialising in hair growth and hair loss prevention with two clinics and in-house pharmacies in Central London, UK. If you are worried about hair loss you can arrange a free consultation with a hair loss expert or complete our Online Consultation Form from anywhere in the world. View our Hair Loss Success Stories, which includes the world’s largest gallery of hair growth comparison photos and demonstrates the levels of success that so many of Belgravia’s patients achieve. You can also phone 020 7730 6666 any time to arrange a free consultation.

Related Stories


Belgravia Centre Hair Loss Treatment Before and After Results - New Success Story

A new entry has just been added to Belgravia’s Male Hair Loss Treatment Success Stories gallery.

Find out what this client had to say and see his regrowth results close up, or find out more about treating Male Pattern Baldness by clicking the buttons below…

(Results may vary and are not guaranteed)

VIEW SUCCESS STORY

Treatment information


Belgravia Centre Hair Loss Clinic Hair Loss Specialist Free ConsultationThe Belgravia Centre

The Belgravia Centre is an organisation specialising in hair growth and hair loss prevention with two clinics and in-house pharmacies in Central London, UK. If you are worried about hair loss you can arrange a free consultation with a hair loss expert or complete our Online Consultation Form from anywhere in the world. View our Hair Loss Success Stories, which includes the world’s largest gallery of hair growth comparison photos and demonstrates the levels of success that so many of Belgravia’s patients achieve. You can also phone 020 7730 6666 any time to arrange a free consultation.

Polycystic ovary syndrome, commonly known as PCOS, is believed to affect 1 in every 5 women in the UK, according to NHS figures.

PCOS polycystic ovary syndrome womens health hair loss

It is an endocrine disorder which affects the normal functioning of the ovaries and can cause both hirsutism (excessive hair growth issues), and hair loss.

Although this shedding can be a side effect of PCOS medication, such as Letrozole (Femara), here we explain why PCOS is often linked to the genetic condition, Female Pattern Hair Loss.

Hyperandrogenism and androgenic alopecia

Hyperandrogenism – the term given to excessive male hormone (androgen) production – is a key symptom associated with PCOS. Androgens are the group of steroid hormones, naturally present in both men and women, that regulate the development of male characteristics.

Female Pattern Hair Loss, also known as androgenetic – or androgenic – alopecia, involves the androgen dihydrotestosterone (DHT) binding to susceptible follicles, causing increasingly thinning hair to the top and frontal, temporal regions of the scalp.

Dihydrostestosterone DHT diagram

Though it can present in those with the relevant genetic predisposition any time following puberty, it is more common for women to develop this type of hair loss when they are in their 30s or 40s.

Due to the fact that stress – whether physical, such as an underlying medical issue eg. PCOS, or emotional – can induce premature hairloss in those with an existing genetic predisposition, there are numerous reports of women now starting to lose their hair in their 20’s – something widely blamed on the pressure of modern life.

For those with PCOS who do not have the relevant inherited predisposition towards Female Pattern Hair Loss, excessive androgen production may cause shedding in a similar pattern.

Female Pattern Hair Loss and hyperandrogenism review

The Journal of Clinical Endocrinology and Metabolism published a report into the associations between Female Pattern Hair Loss and Hyperandrogensim in February 2019, which has recently also appeared in the July issue.

Investigations were carried out by a ‘task force’ of experts in dermatology, endocrinology and reproductive endocrinology, which was appointed by the Androgen Excess and PCOS Society.

The team’s evaluations came from an in-depth, intelligence-gathering exercise using agreed-upon, peer-reviewed studies into Female Pattern Hair Loss, up to December 2017, to determine the most important facts that hair loss specialists and medical practitioners in the field should be aware of.

The following conclusions were drawn:

Womens-hair-loss-consultation-belgravia-centre-hairloss-treatment-regrowth

1 “The term “female pattern hair loss” should be used, avoiding previous terms of alopecia or androgenetic alopecia”; this is due to many women finding the latter wording particularly upsetting.

2 “The two typical patterns of female pattern baldness are centrifugal expansion in the mid scalp, and a frontal accentuation or Christmas tree pattern.” This essentially means that the key areas of the scalp affected by female pattern hair loss, and typical signs, include hair loss that starts as a widening of the (middle) parting and spreads outwards over time as the follicles along the vertex (top of the scalp from hairline to crown), frontal hair loss at the temples.

3 “Isolated female pattern hair loss should not be considered a sign of hyperandrogenism when androgen levels are normal.” Hair loss can be a sign of an underlying health issue, including PCOS. However, as this is an hereditary condition, where there is thinning in the same pattern as genetic hair loss but the patient’s androgen levels are normal, PCOS is unlikely to be a factor.

4 “The assessment of patients with female pattern hairloss is primarily clinical.” There is no need to carry out a biopsy in order to diagnose genetic hair loss. A trained specialist can spot this condition via a scalp assessment and medical information about the patient.

5 “In all patients [thought to potentially have PCOS] with female pattern hair loss, assessment of a possible androgen excess is mandatory. Measurement of vitamin D, iron, zinc, thyroid hormones, and prolactin are optional but recommended.” Belgravia always recommends women worried about losing their hair have a full blood count blood test where possible, specifically covering vitamin levels for vitamin D and vitamin B12, ferritin and zinc, thyroid hormones and diabetes mellitus, before visiting a hair loss specialist for a consultation, and bring their results along with them.

6 “Treatment of female pattern hair loss should start with minoxidil (5%), adding 5α-reductase inhibitors or antiandrogens when there is severe hair loss or hyperandrogenism”. Currently, high strength minoxidil is the only women’s hair loss treatment that is both MHRA-licensed and FDA-approved for this purpose.

Anyone concerned about thinning hair, with or without an additional diagnosis of PCOS, may find a consultation at a dedicated hair loss clinic helpful. That way, a professional hair specialist can provide a confirmed diagnosis and personalised recommendations for appropriate hair loss solutions based upon their findings and the individual’s medical profile.


The Belgravia Centre

The Belgravia Centre is an organisation specialising in hair growth and hair loss prevention with two clinics and in-house pharmacies in Central London, UK. If you are worried about hair loss you can arrange a free consultation with a hair loss expert or complete our Online Consultation Form from anywhere in the world. View our Hair Loss Success Stories, which includes the world’s largest gallery of hair growth comparison photos and demonstrates the levels of success that so many of Belgravia’s patients achieve. You can also phone 020 7730 6666 any time to arrange a free consultation.

Related Stories


Belgravia Centre Hair Loss Treatment Before and After Results - New Success Story

A new entry has just been added to Belgravia’s Female Pattern Hair Loss Treatment Success Stories gallery.

This client has two conditions – Chronic Telogen Effluvium and Female Pattern Hair Loss which are being treated simultaneously.

Find out what this client had to say and see her regrowth results close up, or find out more about treating Chronic Telogen Effluvium and Female Pattern Hair Loss  by clicking the buttons below…

(Results may vary and are not guaranteed)

VIEW SUCCESS STORY

Female Hair Loss Treatment

Chronic Telogen Effluvium Treatment


The Belgravia Centre

The Belgravia Centre is an organisation specialising in hair growth and hair loss prevention with two clinics and in-house pharmacies in Central London, UK. If you are worried about hair loss you can arrange a free consultation with a hair loss expert or complete our Online Consultation Form from anywhere in the world. View our Hair Loss Success Stories, which includes the world’s largest gallery of hair growth comparison photos and demonstrates the levels of success that so many of Belgravia’s patients achieve. You can also phone 020 7730 6666 any time to arrange a free consultation.

Although thinning hair can often be associated with old age, the most common hereditary hair loss conditions – Male Pattern Baldness and Female Pattern Hair Loss – can, in fact, begin any time following puberty in those with the relevant genetic predisposition.

Signs of pattern hair loss have traditionally tended to present later in life for previous generations, usually from mid-to-late 30s and early 40s, worsening in line with age.

Now, however, there appears to be a trend for both men and women beginning to lose their hair from a younger age. This has been noted in countries including the UK, USA and India and has been largely attributed to the increasing pressures of modern living, given both emotional and physical stress are well-established as hairloss triggers.

This is precisely what a May 2019 hair loss survey by the Chinese Youth Network Campus News Agency also found when over half of its participants, who were all reportedly in their 20s or early 30s, claimed to be losing their hair.

Asian college student hair loss from stress and late nights

Over 70% claim ‘mild hair loss’

China Youth Network Campus News Agency received 643 completed questionnaires as part of its survey of students across the country.

The results showed that over 50% (55.568%) of respondents considered they had some kind of hairloss problem, echoing figures from a similar study carried out in 2018. Possibly due to translation issues, this seems to be a conservative number based on further figures later on in the study.

Of all the student respondents, 71.79% rated themselves as having mild hair loss, 15.36% classified themselves as having severe hair loss, and 12.85% identified as being completely bald.

Questions were set to gauge what effects hair loss had on student life and whether or not it affected their studies. The majority of students, at 61.73%, felt it had a ‘minor impact’, 22.35% didn’t believe it had any effect, whilst 15.92% said it had a serious impact.

Additionally, 73.74% of the college students stated having hair loss put them in a bad mood.

Stress and poor diets blamed

When asked – in what appears to be a multiple choice question – what they believed was causing them to lose their hair, the overwhelming majority of students – 88.96% – cited a lack of sleep. This was described as “day and night insomnia”. Close behind, was stress with 80.56% of students pointing to this as the cause of their shedding.

green bun mcdonalds burger china fast food

Other lifestyle issues blamed for hair loss include dietary issues (68.58%), poor hair care (65.94%), ‘poor nutrition‘ (44.01%) and a ‘frequently dyed perm’ (38.1%).

All of these issues can indeed contribute to, or cause, hair thinning with poor dietary habits being linked, particularly in men, to oxidative stress which can, in turn, induce shedding.

Interestingly, only around one-third of respondents believed their hair loss was hereditary (33.59%) or a ‘normal physiological phenomenon’ (30.64%), however.

There are temporary hair loss conditions which can occur at any age, such as Telogen Effluvium, which, though they tend to be more common in women, can also affect men. However, genetic hair loss is by far the more widely seen condition in both men and women.

Telogen Effluvium will generally present around three months after having been triggered by issues such as intense stress, diet or nutritional imbalances, underlying health issues or new medication. It causes hair to shed diffusely from all over the scalp and lasts, on average, for up to six months. Chronic Telogen Effluvium, meanwhile, lasts for at least six months.

Both these temporary hair loss conditions can exacerbate existing cases of Male or Female Pattern Baldness, or spark their premature onset where the individual has an existing genetic predisposition. It is also possible to have a temporary and permanent hair loss condition simultaneously.

These extremely common hereditary complaints cause thinning hair along the top of the scalp, from crown to hairline and temples, only, and are permanent conditions.

A North Sichuan Medical College student, Wang Xiaoqiong, told the pollsters she believed mental and physical stress was to blame for many of her peers’ hair loss, and why many who also worked in the student union, in addition to their studies, complained of a receding hairline:

“Mainly because the life and work stress conference has caused people’s mental state to be in a state of tension, anxiety and irritability for a long time, which leads to endocrine imbalance, affecting the hair growth cycle and causing hair loss during the rest period.”

The views of Lu Yu, a student at Guangdong University of Foreign Studies, echo those of Xiaoqiong. He explains, “They spend their time in leisure and entertainment during the day, habitually staying up late to catch up with their homework or reviewing, and have not formed a series of time planning for themselves. Over time, physical fitness is declining, and [it’s] mentally easy to feel stress and exhaustion. The two together caused the hairline to go backwards.”

Over two-thirds have tried to treat or prevent hair loss

Given its prevalence and negative effect on students’ mental health, it is perhaps unsurprising to find the survey noted 67.88% had already taken measures to alleviate hair loss.

Taking a sensible, holistic approach to heading off the potential causes of shedding, 92.5% advised trying getting more sleep on a regular basis, 80.56% chose better methods of relaxation and 77.6% worked on improving their mental health.

Whilst the translation for the choice made by 75.43% of respondents states they chose “persistence exercise”, we are assuming this means ‘regular exercise’ rather than persistently exercising as constant, excessive exercise has been shown to contribute to hair loss, whereas regular exercise as part of a balanced, healthy lifestyle is recommended.

Of the students surveyed, 27.84% choose to follow hair loss treatment courses featuring clinically-proven hair loss solutions, whilst 25.82 % tried non-medical hair products to reverse thinning hair. A further 15.82% opted for a hair transplant, and 7.9% decided to do nothing and let nature take its course.

Although these figures relate to college students in China, it would certainly be interesting to find out how UK students’ feelings and experiences of hair loss stack up against them.

As the increasing stress of modern society pressures appears to be a worldwide issue, it is likely the attitudes of these Chinese students reflect those of their international counterparts, too.

Anyone concerned about losing more hair than normal or experiencing a noticeable drop in their hair’s volume, would be well-advised to have a consultation with a hair loss specialist.

Belgravia cannot send its treatments or provide assessments for those based in China, though our Central London hair loss clinics and home-use service can send hair treatments to anywhere in the UK and many other countries, following an online consultation.


The Belgravia Centre

The Belgravia Centre is an organisation specialising in hair growth and hair loss prevention with two clinics and in-house pharmacies in Central London, UK. If you are worried about hair loss you can arrange a free consultation with a hair loss expert or complete our Online Consultation Form from anywhere in the world. View our Hair Loss Success Stories, which includes the world’s largest gallery of hair growth comparison photos and demonstrates the levels of success that so many of Belgravia’s patients achieve. You can also phone 020 7730 6666 any time to arrange a free consultation.

Related Stories


Belgravia Centre Hair Loss Treatment Before and After Results - New Success Story

A new entry has just been added to Belgravia’s Male Hair Loss Treatment Success Stories gallery.

Find out what this client had to say and see his regrowth results close up, or find out more about treating Male Pattern Baldness by clicking the buttons below…

(Results may vary and are not guaranteed)

VIEW SUCCESS STORY

Treatment information


Belgravia Centre Hair Loss Clinic Hair Loss Specialist Free ConsultationThe Belgravia Centre

The Belgravia Centre is an organisation specialising in hair growth and hair loss prevention with two clinics and in-house pharmacies in Central London, UK. If you are worried about hair loss you can arrange a free consultation with a hair loss expert or complete our Online Consultation Form from anywhere in the world. View our Hair Loss Success Stories, which includes the world’s largest gallery of hair growth comparison photos and demonstrates the levels of success that so many of Belgravia’s patients achieve. You can also phone 020 7730 6666 any time to arrange a free consultation.

Gin and tonic, fish and chips, Lennon and McCartney… there are some partnerships that just work – and there are other things which really don’t belong together.

One such unfavourable combo is of particular relevance to men who are using hair loss treatment whilst also taking Viagra.

Minoxidil and Viagra

viagra

The MHRA-licensed and FDA-approved topical Male Pattern Baldness treatment, high strength minoxidil and the erectile dysfunction drug – which, whilst commonly known by one of its brand names (Viagra), is also referred to by its active ingredient, sildenafil – are contraindicated.

This means there are risks associated with using both medications simultaneously.

Sildenafil, under the brand name Revatio, is also used to treat pulmonary hypertension and this is also the case for these patients if they are also using minoxidil hair loss solutions.

Minoxidil is a vasodilator; when applied to the scalp to help accelerate localised hair growth, is absorbed into the bloodstream. This can occasionally have cardiovascular effects such as decreased blood pressure, dizziness and headaches due to low blood pressure, and palpitations; taking sildenafil whilst using minoxidil can increase the risk of these issues occurring.

“Usually if patients are using minoxidil and also occasionally take Viagra, we advise them not to use minoxidil on the day they need Viagra. We also update their medical records regularly and monitor their blood pressure anyway,” advises Belgravia hair loss specialist, Rali Bozhinova.

“The other clinically-proven Male Hair Loss Treatment, finasteride 1mg is not contraindicated with Viagra per se – there’s no interaction between the two drugs. However, if a patient has erectile dysfunction, it is Belgravia policy not to prescribe them finasteride due to its possible side effects which include inability to develop or maintain an erection, problems with ejaculation such as reduced amount of ejaculatory fluid, low libido, and infertility.”

Importance of monitoring during treatment

This type of situation is one of the reasons specialists ask anyone having a consultation with a view to possibly starting hair loss treatment at Belgravia to provide certain medical information, including which medications they are currently taking.

The Belgravia Centre london clinic Mens hairloss treatment

This medical history is taken in order to bring up any potential issues which may make them unsuitable for certain hair loss treatments, or so they may be advised how best to combine their medications as safely as possible.

Their information is regularly updated and each patient’s dedicated Treatment Advisor checks in with them throughout their course to find out how they’re getting on and confirm their details are up-to-date.

This supportive approach ensures the client is always on the optimal course for their specific needs or, where necessary, appropriate changes to their treatments are discussed and made.

For those ‘going it alone’ with store-bought hair loss products, it is vital that the patient information leaflet is read fully before use to ensure suitability. Anyone who is not sure whether or not they may be suitable for a particular product should check with a pharmacist, their GP or the manufacturer. This should happen both before treatment begins and again should any significant changes in health or lifestyle – for instance, when starting a new medication – occur.


Circ - Belgravia Centre Hair Loss Clinics LondonThe Belgravia Centre

The Belgravia Centre is an organisation specialising in hair growth and hair loss prevention with two clinics and in-house pharmacies in Central London, UK. If you are worried about hair loss you can arrange a free consultation with a hair loss expert or complete our Online Consultation Form from anywhere in the world. View our Hair Loss Success Stories, which includes the world’s largest gallery of hair growth comparison photos and demonstrates the levels of success that so many of Belgravia’s patients achieve. You can also phone 020 7730 6666 any time to arrange a free consultation.

Related Stories


University Hospital, Bordeaux, France is due to carry out an observational study investigating inflammation in cases of certain autoimmune disorders, including Alopecia Areata.

The aim is to be able to analyse and better explain the relationship between these chronic inflammatory conditions and the function of blood and skin T-cells.

Autoimmune alopecia – whether the scalp-only patchy hair loss of Alopecia Areata, or the more extensive baldness caused by Alopecia Totalis or Alopecia Universalis are known to have links to inflammation – as do many other hair loss conditions.

This study will hopefully expand upon existing knowledge to provide more insight into these enigmatic disorders.

Normal Hair Growth Cycle versus Hair Growth in Alopecia Areata

Single-centre study

The French team will take blood samples and skin biopsies from 450 participants, made up of men and women aged between 18 and 75 years, during the prospective, single-centre trial.

Fifty of the 450 have a diagnosis of Alopecia Areata whilst other subjects have vitiligo, psoriasis or atopic dermatitis.

Although it is not yet recruiting, an estimated completion date of June 2023 has been provided as part of the clinical trial registration.

Treatment criteria

Exclusion criteria for trial participants includes those using certain therapies or systemic treatments, such as acitretin, methotrexate, cyclosporine, Apremilast, infliximab, adalimumab, etanercept, ustekinumab, secukinumab, ixekizumab or dupilumab, for less than four weeks.

Despite methotrexate, cyclosporine, adalimumab and secukinumab being authorised treatments for severe psoriasis, and dupilumab being a proven eczema treatment, all of these five drugs have also been – or are currently being – tested as potential Alopecia Areata treatments.

At present, there are no MHRA-licensed and FDA-approved treatments for Alopecia Areata in any of its phenotypes, though topical applications of high strength minoxidil have been shown to promote hair regrowth in cases of the scalp-only form. This hair loss solution is authorised by both the MHRA and FDA in these ways for the treatment of Male and Female Pattern Baldness.

There are many potential Alopecia Areata, Totalis and Universalis treatments in development, with JAK inhibition looking to be a particularly promising route for all three phenotypes. However, studies like this new French one should help treatment researchers by providing more mechanistically-based information in order to help them understand more about what happens in this hair growth cycle-disrupting condition.


Circ - Belgravia Centre Hair Loss Clinics LondonThe Belgravia Centre

The Belgravia Centre is an organisation specialising in hair growth and hair loss prevention with two clinics and in-house pharmacies in Central London, UK. If you are worried about hair loss you can arrange a free consultation with a hair loss expert or complete our Online Consultation Form from anywhere in the world. View our Hair Loss Success Stories, which includes the world’s largest gallery of hair growth comparison photos and demonstrates the levels of success that so many of Belgravia’s patients achieve. You can also phone 020 7730 6666 any time to arrange a free consultation.

Related Stories